- Home
- CDLR vs APGE Comparison
CDLR vs APGE Comparison
Compare CDLR & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLR
- APGE
- Stock Information
- Founded
- CDLR 2008
- APGE 2022
- Country
- CDLR Denmark
- APGE United States
- Employees
- CDLR N/A
- APGE N/A
- Industry
- CDLR
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CDLR
- APGE Health Care
- Exchange
- CDLR Nasdaq
- APGE Nasdaq
- Market Cap
- CDLR 1.9B
- APGE 2.0B
- IPO Year
- CDLR N/A
- APGE 2023
- Fundamental
- Price
- CDLR $21.23
- APGE $36.88
- Analyst Decision
- CDLR
- APGE Strong Buy
- Analyst Count
- CDLR 0
- APGE 5
- Target Price
- CDLR N/A
- APGE $95.40
- AVG Volume (30 Days)
- CDLR 47.9K
- APGE 483.8K
- Earning Date
- CDLR 08-26-2025
- APGE 11-11-2025
- Dividend Yield
- CDLR N/A
- APGE N/A
- EPS Growth
- CDLR N/A
- APGE N/A
- EPS
- CDLR 0.78
- APGE N/A
- Revenue
- CDLR $546,159,718.00
- APGE N/A
- Revenue This Year
- CDLR $116.02
- APGE N/A
- Revenue Next Year
- CDLR $80.90
- APGE N/A
- P/E Ratio
- CDLR $6.80
- APGE N/A
- Revenue Growth
- CDLR 277.89
- APGE N/A
- 52 Week Low
- CDLR $17.37
- APGE $26.20
- 52 Week High
- CDLR $28.75
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- CDLR 51.41
- APGE 46.24
- Support Level
- CDLR $20.85
- APGE $36.81
- Resistance Level
- CDLR $21.70
- APGE $38.84
- Average True Range (ATR)
- CDLR 0.37
- APGE 1.53
- MACD
- CDLR 0.03
- APGE 0.06
- Stochastic Oscillator
- CDLR 53.72
- APGE 37.97
About CDLR Cadeler AS
Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.